7.6 High-Alert Medications: Digoxin and Electrolytes
Key Takeaways
Digoxin serum concentrations are interpreted by indication and clinical response; draw just before the next dose or at least six hours after the last dose, and do not use a single universal therapeutic target.
Assess heart rate/rhythm and symptoms before digoxin; follow the ordered or institutional hold parameter rather than assuming an adult or infant pulse cutoff applies to every patient.
Hypokalemia and hypomagnesemia increase digoxin toxicity risk; severe acute digoxin poisoning may instead produce dangerous hyperkalemia.
Potassium chloride concentrate is never given IV push: dilute it and infuse with controlled equipment under the product label, prescribed rate, route, laboratory checks, and monitoring.
Diminished or absent reflexes, respiratory depression, and impaired renal excretion are magnesium-toxicity warnings; stop the infusion and escalate per protocol rather than relying on a deterministic serum level.
Digoxin and High-Risk Electrolyte Therapy
These medications can cause serious harm when the dose, route, renal function, or monitoring is wrong. For an NCLEX scenario, identify the patient's symptoms, current prescription, laboratory trend, route, and local protocol before choosing an action. Illustrative laboratory intervals are not universal hold orders or emergency thresholds.
Digoxin: response and toxicity
Digoxin increases myocardial contraction and can slow heart rate and AV conduction. Product labeling lists adult heart failure and chronic atrial fibrillation indications and pediatric heart failure use. Effects, adverse effects, and dose requirements vary with age, lean body weight, renal function, and interacting drugs.
| Assessment | Safe interpretation |
|---|---|
| Heart rate and rhythm | Assess the ordered monitoring parameters and symptoms (dizziness, syncope, bradycardia, conduction disturbance). If a prescribed hold threshold is met or toxicity is suspected, withhold the dose and obtain the ordered clinical review. A pulse below 60/min in adults or 100/min in infants is not a universal product-label hold rule. |
| Serum digoxin | Draw just before the next scheduled dose or at least six hours after the last dose. A level taken soon after dosing can mislead. The label associates levels below 0.5 ng/mL with diminished efficacy and above 2 ng/mL with increased toxicity, but no isolated value proves efficacy or safety; indication and clinical context matter. |
| Renal function and electrolytes | Reduced renal clearance can raise digoxin exposure. Hypokalemia, hypomagnesemia, and hypercalcemia increase susceptibility to toxicity. Review diuretics and other interacting medicines. |
Possible toxicity includes anorexia, nausea, vomiting, visual disturbance, confusion, bradyarrhythmias, AV block, and ventricular arrhythmias. In large acute ingestion, hyperkalemia can signal serious poisoning; do not teach that high potassium simply means digoxin has become ineffective. If toxicity is suspected, hold further digoxin, assess the patient and ECG, notify the responsible clinician or poison service, and obtain directed digoxin/electrolyte/renal tests. Life-threatening arrhythmias or hyperkalemia may require digoxin immune Fab under specialist direction. Digoxin is not effectively removed by dialysis.
IV potassium chloride: route and rate are prescription-specific
Potassium chloride concentrate must be diluted before IV infusion and must never be given IV push. Use a calibrated infusion device, confirm line and concentration, follow the selected product label and local policy, and reassess potassium and clinical status. Some labels describe a usual rate not exceeding 10 mEq/hour in specified circumstances and a carefully monitored higher rate for exceptional severe hypokalemia. These are conditional label instructions, not one universal maximum of 10–20 mEq/hour or fixed 40/80 mEq/L peripheral/central concentrations. Route, vein tolerance, renal function, ECG findings, and monitoring determine the safe plan. Urgent replacement calls for the prescribed monitoring and frequent serum potassium checks.
Potassium disorders: distinguish membrane stabilization, shifting, and removal
Hypokalemia may cause weakness and ECG changes such as T-wave flattening or U waves, but no pattern is pathognomonic. Hyperkalemia may show peaked T waves, conduction slowing, QRS widening, or other changes; a normal ECG does not exclude dangerous hyperkalemia, and some patterns can mimic ischemia. Verify an unexpected result when specimen hemolysis is possible without delaying care for an unstable patient.
| Goal in severe hyperkalemia | Examples and limitation |
|---|---|
| Stabilize myocardium | IV calcium when indicated by the clinical/ECG situation protects the heart but does not lower serum potassium. |
| Shift potassium into cells | Insulin with glucose and inhaled beta-agonist are acute shifting treatments; monitor for hypoglycemia and rebound. Bicarbonate is considered in selected patients with metabolic acidosis, not routine therapy for every elevated potassium result. |
| Remove potassium | Dialysis is considered when potassium is severe or refractory, especially with impaired renal excretion. Diuretics or binders may help in selected patients, but a binder is not a substitute for immediate stabilization or shifting in an unstable emergency. |
Escalation depends on the value and symptoms, renal function, ECG, rate of change, and local critical-result policy. Recheck potassium after treatment because shifting therapies do not remove it from the body.
Magnesium sulfate: clinical monitoring first
Magnesium sulfate is used for seizure prevention/treatment in preeclampsia and eclampsia and other specific indications. During infusion, monitor respiratory status, deep tendon reflexes, urine output/renal function, and ordered serum magnesium. Product labeling notes that reflexes may begin to diminish above about 4 mEq/L, overlapping concentrations used to control convulsions; reflex loss and respiratory paralysis may occur at higher levels, but a neat 4–7 / 5–10 / >10 progression is not a reliable bedside decision rule.
If reflexes disappear, breathing becomes depressed, or toxicity is suspected, stop the infusion, assess airway and breathing, call for urgent help, and follow the protocol. An injectable calcium salt should be available to counteract significant toxicity as ordered; the formulation, dose, and administration rate are protocol-specific. A fixed “1–2 g over three minutes” is not a universal rule. Renal impairment raises accumulation risk, so follow the patient's prescribed urine-output and laboratory parameters rather than treating 30 mL/hour as an all-patient threshold.
Primary references: DailyMed digoxin label; DailyMed potassium chloride concentrate label; DailyMed magnesium sulfate label; KDIGO acute hyperkalemia conference report.
An adult patient has an ordered digoxin hold parameter of heart rate below 60/min. The apical rate is 54/min before the dose, and the patient feels dizzy. What should the nurse do?
Give the dose because the serum level is not yet known
Withhold the dose, assess the patient, and notify the responsible clinician per the order/protocol
Give half the dose without a new order
Ignore the ordered parameter and recheck only at the next routine visit
A patient taking digoxin develops new weakness and a potassium result of 3.1 mEq/L. Which risk deserves attention?
Low potassium proves digoxin is ineffective
Hypokalemia can increase susceptibility to digoxin toxicity
Low potassium rules out digoxin-related arrhythmia
A single potassium result determines the digoxin dose without other assessment
Which cluster of findings in a patient taking digoxin should prompt evaluation for toxicity?
Isolated hunger after exercise
New nausea, visual changes, and an irregular pulse
Stable symptoms with an expected resting pulse
Improved appetite and unchanged rhythm
During a magnesium sulfate infusion for preeclampsia, a patient has newly absent patellar reflexes and slowed breathing. What is the priority nursing response?
Continue the infusion until the next scheduled magnesium level
Stop the infusion, assess airway/breathing, call for urgent help, and prepare ordered calcium treatment per protocol
Increase the infusion because reflex loss is the desired effect
Give a fixed calcium dose and rate without checking the order or local protocol
Sections you finish are checked off in the contents.